Romack Develops Structures Used in Topic Treatments
By Erica Plouffe Lazure
An East Carolina University chemist is working with a Durham-based firm to produce new kinds of polyurethane coatings suitable for pharmaceutical use on humans.
Timothy Romack just completed the first leg of a yearlong contract with Chesson Laboratories this summer.
“We are developing new ways to put polyurethane-based coatings together on a molecular level,” said Romack, who has taught at ECU since 2001. “Here the focus is to design and make the right molecules do the job.”
Romack is designing and testing polymer structures that could, for example, seal and protect wounds or injuries and repel water, but also have pores that are large enough for water vapor to pass, yet still block bacteria. Two ECU students, James Brooks of Fayetteville and Akarsh Manning of Garner, assisted Romack this summer on the project.
Romack said including opportunities for student research is an important part of the partnership with Chesson. The students are learning not only how to apply their knowledge of chemistry principles, Romack said, but they also get to work on a team and figure out how to create a product that could have a real-world application. “I feel it puts their education in context and better prepares them for their careers,” he said.
“Our students have intellectual ownership of these projects; they understand the company and its needs,” Romack said. “ECU is in a unique situation, with excellent research instrumentation and a significant emphasis on undergraduates doing research, there are more opportunities to be involved in leading-edge projects here than in other schools.”
In the past year, Chesson Laboratories has developed a topical application for toe fungus, and three of its products are being submitted as FDA-listed devices. Romack’s polymer chemistry expertise is expected to advance products for applications to treat dermatitis, as well as wound closure and burns. The $30,000 contract, which began in May, will last through 2008 and is expected to lead to additional funding as early as this fall.